SPC199
Alectinib eða salt eða uppleysandi efni þeirra
Status:
VeittApplication date:
10.7.2017Application published:
15.8.2017Grant published:
15.5.2018
Max expiry date:
19.2.2032Medicine name:
AlecensaMedicine for children:
No
Timeline
Today
10.7.2017Application
15.8.2017Publication
15.5.2018Registration
19.2.2032Expires
Marketing license
IS authorization number:
EU/1/16/1169/001Date:
15.3.2017
Foreign authorization number:
EU/1/16/1169Date:
16.2.2017
Owner
Name:
Chugai Seiyaku Kabushiki KaishaAddress:
5-1, Ukima 5-chome, Kita-kuTokyo JP
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221 Hafnarfirði
Patent
Number:
EP2441753